文献速递神经肿瘤

全脑磁共振波谱衍生的代谢特征通过机器学习识别高级别胶质瘤的早期肿瘤进展

Metabolic signatures derived from whole-brain MR-spectroscopy identify early tumor progression in high-grade gliomas using machine learning.
PubMed 文献 · J Neurooncol · 2024-08-24

本研究纳入16例经组织病理学确诊的高级别胶质瘤患者,在治疗后采集全脑磁共振波谱(WB-MRS),共分析118922个体素,涵盖7个感兴趣区。研究开发并验证了5种监督机器学习分类模型和1个神经网络,性能最佳的模型可在治疗后FLAIR信号中预测胶质瘤进展,平均AUC=0.86,Cho/Cr为最重要特征。

要点

  • WB-MRS联合机器学习可区分正常白质、肿瘤及未来进展区域。
  • 最佳模型预测FLAIR信号内胶质瘤进展的平均AUC=0.86。
  • Cho/Cr为预测胶质瘤进展的最重要代谢特征。

核心结论

  • 本研究首次在发现后8个月内揭示治疗后胶质瘤的影像学隐匿性进展。
  • 基于机器学习的WB-MRS生长预测有望指导早期治疗决策。
  • 该研究在预测胶质母细胞瘤复发时间和位置方面代表重要进展。

研究设计与样本

  • 研究纳入16例WB-MRS前经组织病理学确诊的高级别胶质瘤患者,共分析118922个全脑体素。
  • 分析5种局部肿瘤代谢物,覆盖7个感兴趣区:对侧表现正常白质(NAWM)、液体衰减反转恢复(FLAIR)、WB-MRS时强化肿瘤(Tumor)、未来复发区域(AFR)、全脑健康组织(WBH)、非进展性FLAIR(NPF)和进展性FLAIR(PF)。
  • 开发、优化、训练、测试并验证了5种监督机器学习分类模型和1个神经网络。
  • 开发了网络应用以托管新型计算器迈阿密胶质瘤预测图(MGPM),供开源交互使用。

主要发现

  • 机器学习模型成功区分了表现正常白质与肿瘤及未来进展区域。
  • 性能最佳的机器学习模型在治疗后FLAIR信号中预测胶质瘤进展,平均AUC=0.86。
  • Cho/Cr为预测胶质瘤进展的最重要特征。

临床怎么用

  • 作者认为基于机器学习的WB-MRS生长预测有望指导早期治疗决策。
  • 作者认为该研究可预测胶质母细胞瘤复发的时间和位置,从而为治疗决策提供信息以改善患者结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Recurrence for high-grade gliomas is inevitable despite maximal safe resection and adjuvant chemoradiation, and current imaging techniques fall short in predicting future progression. However, we introduce a novel whole-brain magnetic resonance spectroscopy (WB-MRS) protocol that delves into the intricacies of tumor microenvironments, offering a comprehensive understanding of glioma progression to inform expectant surgical and adjuvant intervention. METHODS: We investigated five locoregional tumor metabolites in a post-treatment population and applied machine learning (ML) techniques to analyze key relationships within seven regions of interest: contralateral normal-appearing white matter (NAWM), fluid-attenuated inversion recovery (FLAIR), contrast-enhancing tumor at time of WB-MRS (Tumor), areas of future recurrence (AFR), whole-brain healthy (WBH), non-progressive FLAIR (NPF), and progressive FLAIR (PF). Five supervised ML classification models and a neural network were developed, optimized, trained, tested, and validated. Lastly, a web application was developed to host our novel calculator, the Miami Glioma Prediction Map (MGPM), for open-source interaction. RESULTS: Sixteen patients with histopathological confirmation of high-grade glioma prior to WB-MRS were included in this study, totaling 118,922 whole-brain voxels. ML models successfully differentiated normal-appearing white matter from tumor and future progression. Notably, the highest performing ML model predicted glioma progression within fluid-attenuated inversion recovery (FLAIR) signal in the post-treatment setting (mean AUC = 0.86), with Cho/Cr as the most important feature. CONCLUSIONS: This study marks a significant milestone as the first of its kind to unveil radiographic occult glioma progression in post-treatment gliomas within 8 months of discovery. These findings underscore the utility of ML-based WB-MRS growth predictions, presenting a promising avenue for the guidance of early treatment decision-making. This research represents a crucial advancement in predicting the timing and location of glioblastoma recurrence, which can inform treatment decisions to improve patient outcomes.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Rivera CA, Bhatia S, Morell AA, et al. Metabolic signatures derived from whole-brain MR-spectroscopy identify early tumor progression in high-grade gliomas using machine learning. J Neurooncol. 2024. PMID: 39180640. doi:10.1007/s11060-024-04812-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。